Quanterix Corporation Restructuring Charges
Quanterix Corporation (QTRX) reported Restructuring Charges of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-10
- Quanterix Corporation restructuring charges for the quarter ending 2025-12-31 was $427.00K.
- Quanterix Corporation restructuring charges for the quarter ending 2025-09-30 was $6.30M.
- Quanterix Corporation restructuring charges for the quarter ending 2025-06-30 was $1.30M.
- Quanterix Corporation restructuring charges for the quarter ending 2023-06-30 was $0.00.
- Quanterix Corporation restructuring charges for fiscal 2025 was $8.00M.
- Quanterix Corporation restructuring charges for fiscal 2022 was $3.80M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | ||||||
| 2025-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $6.73M derived: sum of 2 quarters · filed 2026-03-02 | $8.03M derived: sum of 3 quarters · filed 2026-08-10 | $8.00M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $6.30M 10-Q · filed 2025-11-10 | $7.60M derived: sum of 2 quarters · filed 2026-08-10 | $7.57M 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | $1.30M 10-Q · filed 2026-08-10 | $1.30M 10-Q · filed 2026-08-10 | $1.26M 10-Q · filed 2025-08-07 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$33.00K 10-Q · filed 2023-08-08 | $367.00K derived: sum of 3 quarters · filed 2024-12-26 | $3.79M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2023-03-31 | -$33.00K 10-Q · filed 2023-05-09 | $367.00K derived: sum of 2 quarters · filed 2024-12-26 | $3.79M derived: sum of 3 quarters · filed 2024-12-26 | ||||
| 2022-12-31 | $400.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $3.83M derived: sum of 2 quarters · filed 2024-12-26 | $3.80M 10-K/A · filed 2024-12-26 | $3.75M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $3.43M 10-Q · filed 2022-11-09 | $3.40M 10-Q · filed 2023-11-08 | $3.43M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |